Descovy (Emtricitabine/Tenofovir Alafenamide Fumarate)

Descovy Information:

Buy Descovy

Descovy (Emtricitabine/Tenofovir Alafenamide Fumarate) is used for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg. It is often prescribed in combination with other antiretroviral agents as part of a comprehensive HIV treatment regimen. Descovy is also used to reduce the risk of HIV-1 infection from sexual acquisition in adult and adolescent men (who weigh at least 35 kg), except those at risk from receptive vaginal sex. Descovy contains two active ingredients: Emtricitabine and Tenofovir Alafenamide Fumarate (TAF). It belongs to the class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Emtricitabine and Tenofovir Alafenamide work by blocking the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. Emtricitabine is a nucleoside analog, and Tenofovir Alafenamide is a prodrug of tenofovir, another nucleoside analog. Together, they help reduce the viral load in the body, slow down the progression of HIV, and improve the immune system's function.

Generic Descovy from Canada

Canada Drugs Online is proud to serve you the generic Emtricitabine/Tenofovir Alafenamide Fumarate from India also called Tafero EM by Hetero Labs. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other HIV/AIDS Medications such as Dovato and Truvada.

Canadadrugsonline.com supplies only genuine Descovy from Canada shipped using Canadian packaging. This Descovy is manufactured by Gilead Sciences, Inc., the worldwide manufacturer of Descovy. This offer is neither endorsed nor authorized by Gilead Sciences Inc. (the United States and Canadian distributor of Descovy). Canadadrugsonline.com has no affiliation whatsoever with Gilead Sciences Inc.

Descovy Side Effects:

Common mild side effects of this medication include diarrhea, fatigue, back pain, headache, nausea, or a change in the color of the skin on your palms or soles of your feet. Contact your doctor if any of these side effects persist or worsen.

Possible serious side effects of this medication include bone thinning leading to fractures, bone pain, fever or chills, severe diarrhea, shortness of breath, prolonged dizziness, headache, weight loss, or listlessness, yellowing of the skin and eyes, dark urine, light-colored bowel movements, dizziness, fatigue, unusual muscle pain, nausea, vomiting, stomach pain, feeling cold in legs and arms, fast heartbeat, severe body itching and rash, swelling of the face, lips, tongue, or throat, difficulty in breathing, and extreme dizziness. If you notice any of these severe side effects, discontinue this medication immediately and seek urgent medical attention. Additionally, inform your doctor of any other side effects not listed here.

Findings from various clinical studies showed Descovy to produce effective suppression of HIV-1 in infected patients with subsequent slowing down of the progression of the disease. It has also been shown to be effective as pre-exposure prophylaxis, especially in cisgender men and transgender women who engage in sexual activities with men. It has a better renal and bone safety profile when compared to other formulations. It is worth noting that the safety and efficacy of this medication in individuals weighing less than 25 kg or younger than 12 years have not been established. The half-life of Descovy is approximately 0.51 hours for Emtricitabine and 0.51 hours for Tenofovir Alafenamide.

Descovy Directions:

Descovy is available in the form of fixed-dose combination tablets, which should be taken orally with or without food. Your doctor will determine the appropriate dose for you based on your clinical needs and other factors. Refer to the leaflet in the medication pack for additional usage instructions. Take this medication consistently at the same time every day, as prescribed by your doctor, for optimal effects. Missing a dose can impact its effectiveness, particularly when used for pre-exposure prophylaxis. Store Descovy at room temperature and keep it away from children and pets.

Descovy Precautions:

Before using this medication, it is highly important to inform your doctor of any medical condition you previously or currently have, especially:
• Allergic reaction to emtricitabine, tenofovir alafenamide, other ingredients of Descovy, or any other medication;
• Bone problems such as osteoporosis;
• Diabetes;
• Heart disease, including abnormal heart rhythms;
• Kidney disease;
• Liver disease, including hepatitis B infection;
• Mental or mood disorders such as depression;
• Pancreatic diseases such as pancreatitis;
• Seizure disorders

Descovy may cause dizziness, so avoid driving or operating heavy machinery until you know how the medication affects you. Do not use this medication during pregnancy without consulting your doctor first. Consult your doctor immediately if you become pregnant while taking this medication. Women living with HIV infection should not breastfeed. Descovy is not recommended for use in individuals younger than 12 years or weighing less than 25 kg. Some medications can interact with the active ingredients in Descovy, leading to unwanted side effects or reduced effectiveness. Some of these drugs include:
• Antibiotics used to treat tuberculosis, such as rifabutin, rifampicin, and rifapentine;
• Anticonvulsants used to treat epilepsy, such as carbamazepine, oxcarbazepine, phenobarbital, and phenytoin;
• Antiviral medicines such as tipranavir

Therefore, you must inform your healthcare provider about all the medications, including herbal medications and supplements, that you are taking before starting this medication to prevent drug interactions.